The Cancer Research Society announces its 2011 grants at the Institut de
recherches cliniques de Montréal
MONTREAL, Nov. 3, 2011 /CNW Telbec/ - The Cancer Research Society (CRS)
recently announced its 2011 grants during an event held at the Institut
de recherches cliniques de Montréal (IRCM). Three researchers from the
Institut - Drs. Jacques Archambault, Javier M. Di Noia and Tarik Möröy
- received grants totalling $360,000.
"This year, thanks to the generous donors who support its mission, the
Board of the Cancer Research Society approved over 10 million dollars
in grants to Canadian scientists," said Andy Chabot, CRS Executive
Director. "The 47 chosen research projects are the most likely to
contribute to the advancement of cancer research."
These projects will lead to a better understanding of the mechanisms
responsible for the manifestation of cancer, as well as the means to
control different types of cancer, improve treatments and the quality
of life of cancer patients', and prevent the disease.
"My colleagues and I are proud to receive this support from the CRS,"
mentioned Dr Tarik Möröy, IRCM President and Scientific Director, and
Director of the Hematopoiesis and Cancer research unit. "Basic cancer
research is crucial to understand the causes and development of the
disease. These grants will therefore allow us to pursue our innovative
projects in cancer and continue to make progress in the field."
"I would like to call attention to the excellence of the IRCM's
researchers, who obtained nearly 5% of the national grants the SRC has
allocated since 2006, which represents $1,315,400," added Mario
Chevrette, PhD, President of the CRS Board of Directors. "Since 2007,
four of the nine grants given to the Institut ranked among the year's
10 best projects, and one even ranked first in 2009."
Cancer at a glance
Cancer is the leading cause of death in Canada, according to recent data
from Statistics Canada. In fact, this disease represents over 200
different types of disorders. In 2011, approximately 177,800 new cases
and 75,000 deaths will be associated with cancer in the country. In
Quebec, the numbers represent 46,400 new diagnostics and 20,100 deaths.
Based on current incidence rates, one in three Canadians will develop
cancer in his/her lifetime.
About the Institut de recherches cliniques de Montréal (IRCM)
Founded in 1967, the IRCM (www.ircm.qc.ca) is currently comprised of 35 research units in various fields, namely
immunity and viral infections, cardiovascular and metabolic diseases,
cancer, neurobiology and development, systems biology and medicinal
chemistry. It also houses three specialized research clinics, seven
core facilities and three research platforms with state-of-the-art
equipment. The IRCM employs 425 people and is an independent
institution affiliated with the Université de Montréal. The IRCM clinic
is associated to the Centre hospitalier de l'Université de Montréal
(CHUM). The IRCM has a long-standing association with McGill
About the Cancer Research Society
The Cancer Research Society (CRS) is a national not-for-profit
organization whose sole mission is to fund cancer research exclusively
and to offer seed money to the most promising original ideas, projects
and researchers across Canada. During the past 20 years, the Cancer
Research Society has granted over 100 million dollars to some 900
cancer research projects across Canada, including more than 35 million
dollars allocated over the past five years. Founded in 1945, the CRS is
proud to celebrate its 65th anniversary this year. The longevity of CRS is proof of its expertise
and determination in the fight against cancer. To learn more, visit www.CancerResearchSociety.ca.
SOURCE Institut de recherches cliniques de Montréal
For further information: